
About PopVax
PopVax is a Healthcare company based in Hyderabad (India) founded in 2021 by Soham Sankaran. The company has 49 employees. Its Indian entity Popvax Private Limited reported revenue of βΉ56.94 Cr. PopVax offers products and services including mRNA Vaccines, LNP Delivery Platform, and Therapeutics Platform. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
Developer of mRNA platform for vaccines and therapeutics. It offers multivariant thermostable vaccine for SARS-CoV-2 treatment.
- Headquarters Hyderabad, India
- Employees 49
- Founders Soham Sankaran
- SectorsHealthcare
- Website popvax.com
- Social X
- Legal Name Popvax Private Limited
- Date of Incorporation 26 Jul, 2021
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹56.94 Cr
FY 2025 · +45% YoY
- Net Profit₹1.03 Cr
FY 2025 · 2% margin
- EBITDA₹9.18 Cr
FY 2025 · 16% margin
- Latest Funding Round$3.6M (USD), Grant
Sep 2025
- InvestorsBARDA
& 1 more
- Employee Count49
Associated legal entities of PopVax
PopVax operates through Popvax Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Popvax Private Limited CIN U73100MH2021PTC364588 | Active | 26 Jul 2021 | Mumbai, Maharashtra | ₹56.9 Cr | 49 | 2 | View details |
Products & Services of PopVax
PopVax offers a comprehensive portfolio of products and services, including mRNA Vaccines, LNP Delivery Platform, and Therapeutics Platform.
Designs vaccines for COVID-19 and other pathogens using computational methods.
Provides mRNA delivery with novel ionizable lipids for therapeutic applications.
Develops treatments for chronic infections and diseases via protein design.
Funding Insights of PopVax
- Total Rounds 2
- Last Round Grant β $3.6M
- First Round $2M
(Jan 2025)
- Investors Count 2
All 2 funding rounds of PopVax with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $3.6M | Grant | β | β | |
| Jan 2025 | $2M | Grant | β | β |
2 investors in total: 2 institutional.
Investors in PopVax
PopVax has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include BARDA and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BARDA is focused on developing medical countermeasures for public health security. | medicalcountermeasures.gov | United States | ||
Charitable foundation investments on poverty reduction and healthcare | gatesfoundation.org |
Investor details for PopVax
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Popvax Private Limited (PopVax)
Popvax Private Limited is the primary company behind PopVax. The board of Popvax Private Limited currently have 2 directors; the longest-serving is Sahaj Govindarajan Sankaran, appointed in 2021. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sahaj Govindarajan Sankaran DIN 09254190 | Director | 26 Jul 2021 | 5 yrs 3 mo | Popvax Private Limited |
| Soham Govindarajan Sankaran DIN 09254191 | Managing Director | 26 Jul 2021 | 5 yrs 3 mo | Popvax Private Limited |
People of PopVax
4 people are tracked at PopVax (3 in leadership, 1 in team); the tracked headcount is 49.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership | |
Praveen Vittala Kumar | VP Quality And Analytical Sciences | Leadership |
Dr Tushar Ranjan Moharana | Vice President - Protein Design | Leadership |
Gayathri Vijay | Senior Manager - Operations And Supply Chain | Team |
Complete people profiles for PopVax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of PopVax
Figures of Popvax Private Limited, the primary company behind PopVax, for FY 2025. Revenue was ₹56.94 Cr (+45% year on year). Net profit was ₹1.03 Cr (2% margin). EBITDA was ₹9.18 Cr (16% margin). Revenue has grown at a compounded annual rate of +257% over three years.
- ₹56.94 CrRevenue · FY 2025 · +45% YoY
- ₹1.03 CrNet profit · 2% margin
- ₹9.18 CrEBITDA · 16% margin
- ₹1 LakhPaid-up capital
- 49Employees (provident fund records)
- +257%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Popvax Private Limited are on its company page.
Detailed financial statements for PopVax
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PopVax
3 dated milestones of PopVax across 4 years, from founding to its latest funding, stage changes and deals.
- Founded PopVax is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Grant, of $3.6M.
Web traffic of PopVax
The website of PopVax (popvax.com) receives about 8.8K visits a month.
- Monthly visits8.8K
▲ 114.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Popvax
Complete news archive for PopVax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PopVax
PopVax was founded in 2021 and raised its 1st funding round 4 years after it was founded.
PopVax is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
PopVax has 49 employees.
The primary company behind PopVax, Popvax Private Limited, reported revenue of βΉ56.94 Cr for FY 2025, up 45% year on year.
Developer of mRNA platform for vaccines and therapeutics. It offers multivariant thermostable vaccine for SARS-CoV-2 treatment.
PopVax offers mRNA Vaccines, LNP Delivery Platform, and Therapeutics Platform.
PopVax has 2 investors. Key investors include BARDA, and Gates Foundation.
PopVax operates through Popvax Private Limited.
The legal entities of PopVax currently have 2 directors, including Sahaj Govindarajan Sankaran, Soham Govindarajan Sankaran.
